|
US6180604B1
(en)
*
|
1996-08-21 |
2001-01-30 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using analogues of indolicidin
|
|
US6503881B2
(en)
*
|
1996-08-21 |
2003-01-07 |
Micrologix Biotech Inc. |
Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
|
|
IN186245B
(enExample)
|
1997-09-19 |
2001-07-14 |
Ranbaxy Lab Ltd |
|
|
US6172185B1
(en)
*
|
1998-05-20 |
2001-01-09 |
University Of British Columbia |
Antimicrobial cationic peptide derivatives of bactenecin
|
|
GB9818938D0
(en)
|
1998-08-28 |
1998-10-21 |
Alpharma As |
Bioactive peptides
|
|
US8283315B2
(en)
|
1998-08-28 |
2012-10-09 |
Lytix Biopharma As |
Inhibition of tumour growth
|
|
US6288212B1
(en)
*
|
1998-08-28 |
2001-09-11 |
The University Of British Columbia |
Anti-endotoxic, antimicrobial cationic peptides and methods of use therefor
|
|
WO2000026344A1
(en)
*
|
1998-10-30 |
2000-05-11 |
Interlink Biotechnologies Llc |
Peptides with enhanced stability to protease degradation
|
|
US6946261B1
(en)
|
1998-11-20 |
2005-09-20 |
Migenix Inc. |
Efficient methods for producing anti-microbial cationic peptides in host cells
|
|
CN1670217A
(zh)
*
|
1999-02-03 |
2005-09-21 |
特瓦药厂有限公司 |
经微生物学方法制备假单胞菌酸a抗生素的方法
|
|
US6399570B1
(en)
*
|
1999-02-05 |
2002-06-04 |
Agennix, Inc. |
Antimicrobial/endotoxin neutralizing polypeptide
|
|
US20030008369A1
(en)
*
|
1999-03-03 |
2003-01-09 |
Board Of Regents, The University Of Texas System |
Genetic and epigenetic manipulation of ABC transporters and ecto-phosphatases
|
|
EP1163352A1
(en)
*
|
1999-03-17 |
2001-12-19 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants that are resistant to a broad spectrum of pathogens
|
|
US6835868B1
(en)
|
1999-03-17 |
2004-12-28 |
University Of Victoria Innovation And Development Corporation |
Transgenic plants expressing dermaseptin peptides providing broad spectrum resistance to pathogens
|
|
EP1180013B1
(en)
*
|
1999-05-27 |
2006-03-08 |
Biocompatibles UK Limited |
Local drug delivery
|
|
US7015309B1
(en)
|
1999-06-23 |
2006-03-21 |
The Wistar Institute Of Anatomy And Biology |
Pyrrhocoricin-derived peptides, and methods of use thereof
|
|
ES2231275T3
(es)
|
1999-10-08 |
2005-05-16 |
Affinium Pharmaceuticals, Inc. |
Inhibidores de fab i.
|
|
AU782915B2
(en)
*
|
1999-12-20 |
2005-09-08 |
Sa Majeste La Reine Du Chef Du Canada - Agriculture Et Agroalimentaire Canada |
Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
|
|
WO2001053509A2
(en)
*
|
2000-01-21 |
2001-07-26 |
The Wistar Institute Of Anatomy And Biology |
Biocidal molecules, macromolecular targets and methods of production and use
|
|
US8003595B2
(en)
|
2000-03-01 |
2011-08-23 |
Cellectis |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
US6632616B2
(en)
*
|
2000-03-16 |
2003-10-14 |
Duke University |
Compounds that selectively bind to expanded polyglutamine repeat domains and methods of use thereof
|
|
US6777592B2
(en)
*
|
2000-04-14 |
2004-08-17 |
E.I. Du Pont Denemours And Company |
Arthropod defensins of Scolopendra canidens, Vaejovis carolinianus, and Argiope spp.
|
|
DE10030781A1
(de)
*
|
2000-06-29 |
2002-01-17 |
Hassan Jomaa |
Kombinationspräparate von 3-N-Formylhydroxylaminopropylphosphonsäurederivaten oder 3-N-Acetylhydroxylaminopropylphosphonsäurederivaten mit spezielen pharmazeutischen Wirkstoffen
|
|
DE10042853A1
(de)
*
|
2000-08-30 |
2002-04-25 |
Florian Lang |
Nachweis und Beeinflußung der Expression oder Funktion von CD95/CD95L bei Infektionen
|
|
CN1455673A
(zh)
*
|
2001-01-05 |
2003-11-12 |
凯敏工业公司 |
分离自至少部分通过其皮肤进行呼吸的生物体的细菌分离物和衍生自其中的生物活性提取物
|
|
WO2002064183A1
(en)
*
|
2001-02-09 |
2002-08-22 |
Johnson & Johnson Vision Care, Inc. |
Biomedical devices with antimicrobial cationic peptide and protein coatings
|
|
JP4387804B2
(ja)
*
|
2001-04-06 |
2009-12-24 |
アフィニアム・ファーマシューティカルズ・インコーポレイテッド |
ＦａｂＩ阻害剤
|
|
HUP0500797A2
(en)
*
|
2001-06-21 |
2007-06-28 |
Biogal Gyogyszergyar |
Metabolic controlled fermentation process for pseudomonic acid production
|
|
EP1401478A2
(en)
*
|
2001-06-22 |
2004-03-31 |
The Hospital for Sick Children |
Antimicrobial peptides
|
|
US6835536B2
(en)
|
2001-08-21 |
2004-12-28 |
Micrologix Biotech Inc. |
Antimicrobial cationic peptides and formulations thereof
|
|
US8933029B2
(en)
*
|
2001-08-24 |
2015-01-13 |
Carrus Capital Corporation |
Antimicrobial and anti-inflammatory peptides
|
|
KR100438416B1
(ko)
*
|
2001-09-19 |
2004-07-02 |
학교법인조선대학교 |
Ｃａ－ｍａ 펩타이드의 아미노산 중 하나 또는 그 이상을치환하여 ＋ 전극과 소수성 영역이 증가된 신규한펩타이드 및 그를 포함하는 약학적 조성물
|
|
ATE554755T1
(de)
*
|
2001-10-05 |
2012-05-15 |
Steris Inc |
In vitro verfahren, um gegen prionen gerichtete behandlungen abzuschätzen
|
|
US7507787B2
(en)
*
|
2001-12-03 |
2009-03-24 |
The University Of British Columbia |
Effectors of innate immunity
|
|
EP1455769A4
(en)
|
2001-12-28 |
2004-09-22 |
Biogal Gyogyszergyar |
METHOD FOR PRODUCING CRYSTALLINE AND AMORPHIC MUPIROCIN CALCIUM
|
|
US20040052928A1
(en)
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
|
US20030219854A1
(en)
*
|
2002-03-21 |
2003-11-27 |
Micrologix Biotech Inc. |
Methods for producing modified anti-infective peptides
|
|
EP1487432B1
(en)
*
|
2002-03-26 |
2013-03-06 |
Eastern Virginia Medical School |
Suramin and derivatives thereof as topical microbicide and contraceptive
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
FR2839311A1
(fr)
*
|
2002-05-06 |
2003-11-07 |
Entomed |
Peptides antibacteriens, genes codant les peptides, vecteurs, organismes transformes, leurs preparations et les compositions les contenant
|
|
EP1360961A1
(en)
*
|
2002-05-07 |
2003-11-12 |
AM-Pharma B.V. |
Use of antimicrobial peptides for potentiating the activity of antimicrobial agents
|
|
IL150907A
(en)
*
|
2002-07-25 |
2007-07-04 |
Stephan Cherkez |
Process for the preparation of stable amorphous calcium pseudomonate
|
|
AU2003304204B2
(en)
*
|
2002-10-29 |
2009-12-24 |
Insmed Incorporated |
Sustained release of antiinfectives
|
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
PT1575951E
(pt)
|
2002-12-06 |
2014-09-15 |
Debiopharm Int Sa |
Compostos heterocíclicos, métodos para os preparar e sua utilização em terapia
|
|
BR0316776A
(pt)
*
|
2002-12-10 |
2005-10-25 |
Biosynexus Inc |
Formula para anti-infeccioso tópico
|
|
DE10260537A1
(de)
*
|
2002-12-21 |
2004-07-15 |
Kerek, Franz, Dr. |
Peptide mit hohem Cysteingehalt
|
|
EP1608377B1
(en)
*
|
2003-03-17 |
2008-10-01 |
Affinium Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
|
|
PL1468697T3
(pl)
*
|
2003-04-14 |
2008-05-30 |
Wyeth Corp |
Kompozycje zawierające piperacyklinę i tazobaktam przydatne do wstrzykiwań
|
|
US6900184B2
(en)
|
2003-04-14 |
2005-05-31 |
Wyeth Holdings Corporation |
Compositions containing pipercillin and tazobactam useful for injection
|
|
AU2003230899A1
(en)
*
|
2003-04-14 |
2004-11-26 |
Wyeth Holdings Corporation |
Compositions containing piperacillin and tazobactam useful for injection
|
|
US6989370B2
(en)
*
|
2003-05-01 |
2006-01-24 |
The United States Of America As Represented By The Secretary Of Agriculture |
Bacteriocins and novel bacterial strains
|
|
SE0301431D0
(sv)
|
2003-05-19 |
2003-05-19 |
Dermagen |
Novel antimicrobial peptides
|
|
US7220422B2
(en)
*
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
CN101415724B
(zh)
*
|
2003-06-30 |
2015-12-02 |
特拉维夫大学未来科技开发有限公司 |
肽、抗肽抗体以及用它们来诊断和治疗淀粉样蛋白相关疾病的方法
|
|
US20060121083A1
(en)
*
|
2003-07-18 |
2006-06-08 |
Technion Research & Development Foundation Ltd. |
Anti-microbial medical implants and uses thereof
|
|
AU2003904225A0
(en)
*
|
2003-08-08 |
2003-08-21 |
Ripetech Pty Limited |
Method for reducing precure during the curing of thermosetting resins
|
|
WO2005016960A2
(en)
*
|
2003-08-14 |
2005-02-24 |
Diatos |
Amino acid sequences facilitating penetration of a substance of interest into cells and/or cell nuclei
|
|
FR2858772A1
(fr)
*
|
2003-08-14 |
2005-02-18 |
Diatos |
Composition anti bacterienne, plus particulierement contre les bacteries gram negatif, comprenant un peptide et un agent anti-bacterien avantageusement hydrophobe
|
|
US20050108047A1
(en)
*
|
2003-11-19 |
2005-05-19 |
Vvii Newco 2003, Inc. |
Business methods for commercializing antibiotics
|
|
US7455840B2
(en)
*
|
2003-11-19 |
2008-11-25 |
The Scripps Research Institute |
Compositions and methods to reduce mutagenesis
|
|
CA2559208A1
(en)
*
|
2004-03-17 |
2005-09-29 |
Mpex Pharmaceuticals, Inc. |
Use and administration of bacterial efflux pump inhibitors
|
|
US7994225B2
(en)
*
|
2004-03-17 |
2011-08-09 |
Rempex Pharmaceuticals, Inc. |
Bacterial efflux pump inhibitors for the treatment of ophthalmic and otic infections
|
|
WO2005090385A2
(en)
*
|
2004-03-18 |
2005-09-29 |
Ansata Therapeutics, Inc. |
Compositions having antimicrobial activity and uses thereof
|
|
ATE458476T1
(de)
*
|
2004-06-01 |
2010-03-15 |
Teva Gyogyszergyar Zartkoeruen |
Verfahren für die zubereitung der amorphen form eines medikamentes
|
|
US8450307B2
(en)
*
|
2004-06-04 |
2013-05-28 |
Affinium Pharmaceuticals, Inc. |
Therapeutic agents, and methods of making and using the same
|
|
WO2006006172A2
(en)
*
|
2004-07-15 |
2006-01-19 |
Ramot At Tel Aviv University Ltd. |
Use of anti-amyloid agents for treating and typing pathogen infections
|
|
DK1927597T3
(en)
*
|
2004-08-18 |
2017-02-13 |
Novabiotics Ltd |
ANTIBACTERIAL PEPTIDES
|
|
US7700308B2
(en)
*
|
2004-09-16 |
2010-04-20 |
University Of Washington |
Methods for determining susceptibility to dental caries
|
|
WO2006049580A1
(en)
*
|
2004-11-04 |
2006-05-11 |
National University Of Singapore |
Anticoagulant peptides
|
|
EP1657249A1
(en)
*
|
2004-11-10 |
2006-05-17 |
Nederlandse Organisatie voor toegepast-natuurwetenschappelijk Onderzoek TNO |
Antibiotic drosocin derivatives
|
|
SE0402807D0
(sv)
*
|
2004-11-17 |
2004-11-17 |
Dermagen Ab |
Novel antimicrobial peptides
|
|
US8252737B2
(en)
|
2004-12-15 |
2012-08-28 |
The Regents Of The University Of Colorado |
Antimicrobial peptides and methods of use
|
|
EP1858488B2
(en)
*
|
2005-03-14 |
2022-07-20 |
Wyeth LLC |
Tigecycline compositions and methods of preparation
|
|
CA2603179A1
(en)
*
|
2005-04-05 |
2006-10-12 |
The Scripps Research Institute |
Compositions and methods for enhancing drug sensitivity and treating drug resistant infections and diseases
|
|
CA2617133C
(en)
|
2005-07-28 |
2014-09-30 |
Biosynexus Incorporated |
Compositions and methods for treating bacteria
|
|
US20090156578A1
(en)
*
|
2005-12-05 |
2009-06-18 |
PAULS Henry |
3-Heterocyclylacrylamide Compounds as Fab I Inhibitors and Antibacterial Agents
|
|
ES2798263T3
(es)
|
2005-12-08 |
2020-12-10 |
Insmed Inc |
Composiciones a base de lípidos de antiinfecciosos para tratar infecciones pulmonares
|
|
JP2009526045A
(ja)
*
|
2006-02-10 |
2009-07-16 |
デルマゲン アクティエボラーグ |
新規抗菌ペプチド及びその使用
|
|
JP2009526046A
(ja)
*
|
2006-02-10 |
2009-07-16 |
デルマゲン アクティエボラーグ |
新規分子
|
|
WO2007117550A2
(en)
*
|
2006-04-06 |
2007-10-18 |
Transave, Inc. |
Methods for coacervation induced liposomal encapsulation and formulations thereof
|
|
AU2007250558B2
(en)
|
2006-05-16 |
2012-10-25 |
Pergamum Ab |
Improved antimicrobial peptides
|
|
IL176303A0
(en)
*
|
2006-06-14 |
2006-10-05 |
Shmuel Shraga |
Pharmaceutical composition for the treatment of otomycosis
|
|
EP2054422B1
(en)
|
2006-07-20 |
2017-06-14 |
Debiopharm International SA |
Acrylamide derivatives as fab i inhibitors
|
|
WO2008033119A1
(en)
*
|
2006-09-12 |
2008-03-20 |
Chaperone Technologies, Inc. |
Novel combinations of dnak inhibitors with known antibacterial agents
|
|
US20080139518A1
(en)
*
|
2006-12-04 |
2008-06-12 |
Concert, Llc |
Topical compositions for treatment of skin conditions
|
|
WO2008098374A1
(en)
*
|
2007-02-16 |
2008-08-21 |
Affinium Pharmaceuticals, Inc. |
Salts, prodrugs and polymorphs of fab i inhibitors
|
|
WO2008137717A1
(en)
|
2007-05-04 |
2008-11-13 |
Transave, Inc. |
Compositions of multicationic drugs for reducing interactions with polyanionic biomolecules and methods and uses thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
US20090099062A1
(en)
*
|
2007-05-31 |
2009-04-16 |
Ethan Lee |
Pyrvinium For The Treatment of Cancer
|
|
WO2009009156A2
(en)
*
|
2007-07-06 |
2009-01-15 |
Laclede, Inc. |
Use of hydrolytic and oxidative enzymes to dissolve biofilm in airway passages
|
|
DE102007036128A1
(de)
*
|
2007-07-23 |
2009-02-12 |
Universität Leipzig |
Antibiotische Peptide
|
|
KR20100059863A
(ko)
*
|
2007-09-11 |
2010-06-04 |
몬도바이오테크 래보래토리즈 아게 |
치료제로서의 펩티드 티모신 베타 ４ 단독 또는 세크로핀 ａ와의 배합물의 용도
|
|
WO2009033667A2
(en)
*
|
2007-09-11 |
2009-03-19 |
Mondobiotech Laboratories Ag |
Use of a peptide as a therapeutic agent
|
|
DE102008031283A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit von durch Trichomonadida hervorgerufenen Krankheiten
|
|
DE102008031284A1
(de)
*
|
2008-07-02 |
2010-01-07 |
Bayer Schering Pharma Aktiengesellschaft |
Neue Bekämpfungsmöglichkeit der Giardiose
|
|
US20100008897A1
(en)
*
|
2008-07-09 |
2010-01-14 |
Susan Daly |
Composition for providing a benefit to a keratin-containing substrate
|
|
GB0815484D0
(en)
*
|
2008-08-26 |
2008-10-01 |
Univ Leuven Kath |
Antibacterial agents
|
|
WO2010042534A1
(en)
*
|
2008-10-06 |
2010-04-15 |
The Regents Of The University Of Colorado, A Body Corporate |
Peptides and methods of use
|
|
EP2437770A4
(en)
*
|
2009-06-05 |
2013-11-06 |
Univ Colorado Regents |
ANTIMICROBIAL PEPTIDES
|
|
PL2445515T3
(pl)
|
2009-06-26 |
2016-10-31 |
|
Środki przeciwdrobnoustrojowe
|
|
US20120195872A1
(en)
*
|
2009-06-26 |
2012-08-02 |
Lysando Ag |
Antimicrobial agents
|
|
TW201125577A
(en)
*
|
2009-12-02 |
2011-08-01 |
Novozymes As |
Use of defensins for treatment of infective endocarditis
|
|
RU2013126706A
(ru)
|
2010-11-15 |
2014-12-27 |
Рамот Ат Тель-Авив Юниверсити Лтд. |
Дипептидные аналоги для лечения состояний, ассоциированных с образованием амилоидных фибрилл
|
|
US20130345249A1
(en)
*
|
2011-01-15 |
2013-12-26 |
The Regents Of The University Of California |
Formulations for the prevention and treatment of Wolbachia-related disease
|
|
PL2852391T3
(pl)
|
2012-05-21 |
2022-04-11 |
Insmed Incorporated |
Układy do leczenia infekcji płuc
|
|
EP2861608B8
(en)
|
2012-06-19 |
2019-06-19 |
Debiopharm International SA |
Prodrug derivatives of (e)-n-methyl-n-((3-methylbenzofuran-2-yl)methyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide
|
|
CA2891487A1
(en)
|
2012-11-29 |
2014-06-05 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
US9603896B2
(en)
|
2012-12-03 |
2017-03-28 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
US9096679B2
(en)
|
2012-12-03 |
2015-08-04 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and methods of production and use thereof
|
|
JP6405365B2
(ja)
|
2013-04-16 |
2018-10-17 |
ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティ オブ オクラホマ |
ペプチド化合物及びその製造方法及びその使用
|
|
US20200157159A1
(en)
|
2013-04-16 |
2020-05-21 |
The Board Of Regents Of The University Of Oklahoma |
Peptide compounds and compositions thereof
|
|
CA2911919A1
(en)
|
2013-05-10 |
2014-11-13 |
Academisch Ziekenhuis Leiden H.O.D.N. Lumc |
Antimicrobial peptide
|
|
KR101550965B1
(ko)
*
|
2013-07-31 |
2015-09-07 |
씨제이제일제당 (주) |
초고압을 이용한 야채류 식품의 제조방법
|
|
US10059752B2
(en)
*
|
2013-10-14 |
2018-08-28 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
US10751440B2
(en)
*
|
2013-10-14 |
2020-08-25 |
University Of Houston System |
Esculentin 1a derivatives and uses thereof
|
|
EP3632457A1
(en)
*
|
2013-10-31 |
2020-04-08 |
Hutchison Biofilm Medical Solutions Limited |
Use of peptides in antibiotic resistance
|
|
US20160250298A1
(en)
|
2013-11-01 |
2016-09-01 |
Spherium Biomed S.L. |
Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
|
|
MX384843B
(es)
|
2014-05-15 |
2025-03-14 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas.
|
|
US10791740B2
(en)
|
2014-06-06 |
2020-10-06 |
The Curators Of The University Of Missouri |
Enhancement of antibiotic efficacy
|
|
SG11201703307WA
(en)
*
|
2014-10-24 |
2017-05-30 |
Redhill Biopharma Ltd |
Therapy for inhibition of single-stranded rna virus replication
|
|
WO2016132359A2
(en)
*
|
2015-02-22 |
2016-08-25 |
Omnix Medical Ltd. |
Antimicrobial peptides
|
|
KR101773390B1
(ko)
*
|
2015-05-08 |
2017-08-31 |
동아인코팜 주식회사 |
여드름 개선용 화장료 조성물
|
|
UA125747C2
(uk)
|
2015-09-01 |
2022-06-01 |
Фьост Вейв Байо, Інк. |
Способи та композиції для лікування станів, пов'язаних із аномальною запальною відповіддю
|
|
US12594285B2
(en)
|
2016-02-25 |
2026-04-07 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
|
US12447166B2
(en)
|
2016-02-25 |
2025-10-21 |
Applied Biological Laboratories, Inc. |
Compositions and methods for protecting against airborne pathogens and irritants
|
|
EP3419629A4
(en)
|
2016-02-25 |
2019-10-30 |
Applied Biological Laboratories, Inc. |
COMPOSITIONS AND PROCEDURES FOR PROTECTION AGAINST AIRBORNE PATHOGENES AND IRRITATES
|
|
DK3419628T3
(da)
|
2016-02-26 |
2021-01-11 |
Debiopharm Int Sa |
Medikament til behandling af diabetiske fodinfektioner
|
|
US11185555B2
(en)
|
2016-04-11 |
2021-11-30 |
Noah James Harrison |
Method to kill pathogenic microbes in a patient
|
|
ITUA20163612A1
(it)
*
|
2016-05-19 |
2017-11-19 |
Icf Srl |
Nuovi composti attivi contro microorganismi patogeni
|
|
WO2017223098A1
(en)
|
2016-06-21 |
2017-12-28 |
The Curators Of The University Of Missouri |
Bis-amino acid based compound and use thereof
|
|
CN106589135B
(zh)
*
|
2016-11-25 |
2018-08-28 |
东北农业大学 |
一种靶向抗菌肽及其制备方法和应用
|
|
WO2018140518A1
(en)
|
2017-01-24 |
2018-08-02 |
Flagship Pioneering, Inc. |
Compositions and related methods for controlling vector-borne diseases
|
|
CN110831432A
(zh)
|
2017-01-24 |
2020-02-21 |
旗舰创业创新五公司 |
用于农业的组合物和相关方法
|
|
AU2018212575B2
(en)
|
2017-01-24 |
2022-07-07 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for controlling vector-borne diseases
|
|
UA127733C2
(uk)
*
|
2017-01-24 |
2023-12-20 |
Флегшіп Пайонірінг Інновейшнз V, Інк. |
Композиції і відповідні способи для сільського господарства
|
|
BR122022016119B1
(pt)
|
2017-01-24 |
2023-11-21 |
Flagship Pioneering Innovations V, Inc |
Métodos para aumentar o perfil nutricional de um inseto e para aumentar a taxa de desenvolvimento de um inseto e usos de bactérias
|
|
CA3048497A1
(en)
|
2017-02-24 |
2018-08-30 |
Flagship Pioneering Innovations V, Inc. |
Compositions and related methods for modulating endosymbionts
|
|
EP3773505B1
(en)
|
2018-03-30 |
2026-04-29 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
|
EP3787602A4
(en)
|
2018-05-02 |
2022-03-23 |
Insmed Incorporated |
PROCESS FOR THE MANUFACTURE OF LIPOSOMAL DRUG FORMULATIONS
|
|
CN108434438B
(zh)
*
|
2018-06-22 |
2020-08-25 |
安徽科技学院 |
抗菌肽在制备治疗幽门螺杆菌病的药物中的用途以及药物组合物
|
|
ES2944535T3
(es)
|
2019-02-14 |
2023-06-22 |
Debiopharm Int Sa |
Formulación de afabicina, método para preparar la misma
|
|
UA129222C2
(uk)
|
2019-06-14 |
2025-02-12 |
Дебіофарм Інтернешнл С.А. |
Лікарський засіб і його застосування для лікування бактеріальних інфекцій, пов'язаних з біоплівкою
|
|
US11471433B1
(en)
|
2019-08-01 |
2022-10-18 |
Flagship Pioneering Innovations V, Inc. |
Postbiotic compositions and related methods for agriculture
|
|
US10980756B1
(en)
|
2020-03-16 |
2021-04-20 |
First Wave Bio, Inc. |
Methods of treatment
|
|
AU2021335500A1
(en)
|
2020-09-04 |
2023-05-04 |
Elanco Us Inc. |
Palatable formulations
|
|
EP4213876A4
(en)
*
|
2020-09-17 |
2024-09-25 |
Board of Regents, The University of Texas System |
PHARMACEUTICAL COMPOSITIONS OF NICLOSAMIDE AND A PROTEIN
|
|
WO2026042045A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
Indolicidine-containing compositions for personal care/hygiene applications
|
|
WO2026041926A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
A synergistic combination of an antimicrobial peptide and actives for hygiene applications
|
|
WO2026041925A1
(en)
|
2024-08-22 |
2026-02-26 |
Itc Limited |
A synergistic composition of an antimicrobial peptide (amp) and natural active
|
|
CN119350439B
(zh)
*
|
2024-08-26 |
2025-12-30 |
海南大学 |
一种具有抗白色念珠菌活性的短链抗菌肽及其应用
|